RxDoctor Payments Data

Gilberto Rodriguez, PA

Medical · Pembroke Pines, FLNPI 1881084077

Payments from drug & device makers

$562in general payments, 2019–2025

Across 30 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$198
  • Lilly USA, LLC$116
  • Boehringer Ingelheim$101
  • AstraZeneca$38
  • Gilead$31
  • Bayer$27
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$562100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie12$198
Lilly USA, LLC6$116
Boehringer Ingelheim5$101
AstraZeneca2$38
Gilead1$31
Bayer1$27
Pfizer1$21
Novo Nordisk1$17
GSK1$14

How this compares

$562 in reported general payments places this provider in the 45th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$8,532
Medicare patients
60
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin33$45,118
EliquisApixaban34$34,609
TrulicityDulaglutide18$18,726
VemlidyTenofovir Alafenamide11$15,540
FarxigaDapagliflozin Propanediol16$14,621
LinzessLinaclotide19$14,130
TradjentaLinagliptin11$6,534
SymbicortBudesonide/Formoterol Fumarate20$4,984
Novolog FlexpenInsulin Aspart16$3,849
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$3,310
Albuterol Sulfate HfaAlbuterol Sulfate71$1,750
Rosuvastatin Calcium132$1,127
Atorvastatin Calcium157$1,118
Diclofenac Sodium40$958
ValacyclovirValacyclovir Hcl26$898

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$101$51,65244 claims
PfizerEliquis$21$34,60934 claims
AstraZenecaFarxiga, Symbicort$38$19,60536 claims
Lilly USA, LLCTrulicity$116$18,72618 claims
GileadVemlidy$31$15,54011 claims
AbbVieLinzess$198$14,13019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,031 medical providers in Florida.

Other medical in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →